Inhibition of angiogenesis was also observed in the treatment of gastric cancer using siRNA against hepatocyte growth factor (HGF); in this case, the EV-siRNA system suppressed not only angiogenesis but also tumor growth, both in vitro and in vivo, through downregulation of HGF and subsequently of VEGF [123]. The gene discussed is HGF; the disease is gastric cancer.